1[4]Gournay J, Tchuenbou J, Richou C, Masliah C, Lerat F, Dupas B, Martin T, Nouel JF, Schnee M, Montigny P, D'Alincourt A, Hamy A, Paineau J, Le Neel JC, Le Borgne J, Galmiche JP.Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective casecontrol study with cost analysis. Aliment Pharmacol Ther 2002;16:1529-1538
2[5]Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N,Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928
3[6]Groupe d'Etude et de Traitement du Carcimome Hepatocelltaire.A comparison of lipiodol, chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261
4[7]Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003; 237:171-179
5[8]Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM,Preskitt JT. Cryosurgical ablation of hepatic tumors. Am J Surg 1997; 174:614-618
6[9]Lam CM, Yuen WK, Fan ST. Hepatic cryoablation for recurrent hepatocellular carcinoma after hepatectomy:a preliminary report.Xu KC et al. Cryoablation for hepatocellular carcinoma J Surg Oncol 1998; 68:104-106
7[10]Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002; 89:1396-1401
8[11]Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1988; 61:1889-1892
9[12]Zhou XD, Tang ZY, Yu YQ, Weng JW, Ma ZC, Zhang BH, Zheng YX. The role of cryosurgery in the treatment of hepatic cancer:areport of 113 cases. J Cancer Res Clin Oncol 1993; 120:100-102
10[13]Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours-a practical guide. HPB Surg 1995; 8:167-173
9Wan-Ping Chen, Xin He, Qi-Fa Ye and Ke Li Institute of Organ Transplantation, Third Xiangya Hospital, Xiangya Medical College, Central South University, Changsha 410013, China, and Institute of Clinical Pharmacology, Xiangya Medical College, Central South University, Changsha 410078, China.Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):391-395. 被引量：2
